ARKK vs PDEX
ARK Innovation ETF (ARKK) versus Pro-Dex Inc (PDEX) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Pro-Dex Inc (PDEX) is a medical instruments & supplies company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported PDEX revenue for 2025-06-30 was $66.6M. Net income was $155.0K. Revenue was up 23.7% from 2024-06-30 to 2025-06-30. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
ARKK currently screens at market cap $0. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
Not investment advice. Open the ARKK and PDEX stock pages for the full models.
Not investment advice.